These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 4743269

  • 1. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh, Kandel' EI, Vasil'ev VN, Iadgarov IS, Bol'shakova TD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M, Tanabe H, Yano Y, Nakao K.
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M, Vardi Y, Kesten M, Oberman Z, Herzberg M.
    Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
    [No Abstract] [Full Text] [Related]

  • 5. The biochemistry of catecholamines in relation to Parkinson's disease.
    Hinterberger H.
    Aust N Z J Med; 1971 May; 1():Suppl 1:14-8. PubMed ID: 5292808
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI, Iadgarov IS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical investigations in patients with Parkinson's disease treated with L-dopa.
    Jequier E, Dufresne JJ.
    Neurology; 1972 Jan; 22(1):15-21. PubMed ID: 5061836
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
    Jones DG, Turnbull MJ, Lenman JA, Robertson MA.
    J Neurol Sci; 1972 Nov; 17(3):245-53. PubMed ID: 4653961
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM, Miller S, Gunder M.
    Acta Derm Venereol; 1983 Nov; 63(2):97-101. PubMed ID: 6189350
    [Abstract] [Full Text] [Related]

  • 13. [Catecholamine excretion in children with neurogenic tumors of the mediastinum].
    Stepanov EA, Bukhny AE, Bol'shakova TD, Lukicheva TI.
    Khirurgiia (Mosk); 1972 Jun; 48(6):125-8. PubMed ID: 5043043
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
    Wocial B, Januszewicz W, Gryglas P, Januszewicz A, Feltynowski T, Lapiński M.
    Przegl Lek; 1997 Jun; 54(11):793-8. PubMed ID: 9501691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of veloergometric exercise to the limit of endurance on indices of the sympatho-adrenal system in subjects with different degrees of physical training].
    Men'shikov VV, Bol'shakova TD, Erez VP, Lukicheva TI, Dubobes GK.
    Probl Endokrinol (Mosk); 1973 Jun; 19(1):45-51. PubMed ID: 4698455
    [No Abstract] [Full Text] [Related]

  • 17. Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine.
    Molnár G, Fodor A.
    Ther Hung; 1973 Jun; 21(1):35-40. PubMed ID: 4792890
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Biochemical evaluation of the effectiveness of antiparkinson preparations containing L-DOPA].
    Vartanian KZ.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Jun; 81(12):1777-81. PubMed ID: 6803476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.